Histones as mediators of host defense, inflammation and thrombosis

Future Microbiology

Volumn 11, Issue 3, 2016, Pages 441-453

  Hoeksema, Marloes ^a,b   Van Eijk, Martin ^b   Haagsman, Henk P ^b   Hartshorn, Kevan L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

antimicrobial peptides; histones; innate immunity; neutrophils; platelets

Indexed keywords

HISTONE; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; INFLAMMASOME; POLYPEPTIDE ANTIBIOTIC AGENT; SERINE PROTEINASE; THROMBIN; TOLL LIKE RECEPTOR; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; BACTERIAL MEMBRANE; ESCHERICHIA COLI; EXTRACELLULAR TRAP; HOST RESISTANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; LIVER; LUNG; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOSIS; ANIMAL; CHEMISTRY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFECTIVE AGENTS; EXTRACELLULAR TRAPS; HISTONES; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INFLAMMATION; SEPSIS; THROMBOCYTOPENIA; THROMBOSIS; TOLL-LIKE RECEPTORS;

EID: 84962434111     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.151     Document Type: Review

References (109)

1. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648), 251-260 (1997).
2. Allan J, Hartman PG, Crane-Robinson C, Aviles FX. The structure of histone H1 and its location in chromatin. Nature 288(5792), 675-679 (1980).
3. Delange RJ, Smith EL. Histones: structure and function. Annu. Rev. Biochem. 40, 279-314 (1971).
4. Arents G, Burlingame RW, Wang BC, Love WE, Moudrianakis EN. The nucleosomal core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-handed superhelix. Proc. Natl Acad. Sci. USA 88(22), 10148-10152 (1991).
5. Verdone L, Caserta M, Di Mauro E. Role of histone acetylation in the control of gene expression. Biochem. Cell Biol. 83(3), 344-353 (2005).
6. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 21(3), 381-395 (2011).
7. Ragunathan K, Jih G, Moazed D. Epigenetics. Epigenetic inheritance uncoupled from sequence-specific recruitment. Science 348(6230), 1258699 (2015).
8. Konishi A, Shimizu S, Hirota J et al. Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell 114(6), 673-688 (2003).
9. Garg M, Perumalsamy LR, Shivashankar GV, Sarin A. The linker histone h1.2 is an intermediate in the apoptotic response to cytokine deprivation in T-effectors. Int. J. Cell. Biol. 2014, 674753 (2014).
10. Muhlhausser P, Muller EC, Otto A, Kutay U. Multiple pathways contribute to nuclear import of core histones. EMBO J. 2(8), 690-696 (2001).
11. Zlatanova JS, Srebreva LN, Banchev TB, Tasheva BT, Tsanev RG. Cytoplasmic pool of histone H1 in mammalian cells. J. Cell Sci. 96 (Pt 3), 461-468 (1990).
12. Watson K, Edwards RJ, Shaunak S et al. Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells. Biochem. Pharmacol. 50(3), 299-309 (1995).
13. Anand P, Cermelli S, Li Z et al. A novel role for lipid droplets in the organismal antibacterial response. eLife 1, e00003 (2012).
14. Li GH, Mine Y, Hincke MT, Nys Y. Isolation and characterization of antimicrobial proteins and peptide from chicken liver. J. Pept. Sci. 13(6), 368-378 (2007).
15. Park CB, Kim MS, Kim SC. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem. Biophys. Res. Commun. 218(1), 408-413 (1996).
16. Kawasaki H, Isaacson T, Iwamuro S, Conlon JM. A protein with antimicrobial activity in the skin of Schlegel's green tree frog Rhacophorus schlegelii (Rhacophoridae) identified as histone H2B. Biochem. Biophys. Res. Commun. 312(4), 1082-1086 (2003).
17. Hiemstra PS, Eisenhauer PB, Harwig SS, Van Den Barselaar MT, Van Furth R, Lehrer RI. Antimicrobial proteins of murine macrophages. Infect. Immun. 61(7), 3038-3046 (1993).
18. Lemaire S, Shukla VK, Rogers C et al. Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity. Eur. J. Pharmacol. 245(3), 247-256 (1993).
19. Lee DY, Huang CM, Nakatsuji T et al. Histone H4 is a major component of the antimicrobial action of human sebocytes. J. Invest. Dermatol. 129(10), 2489-2496 (2009).
20. Rose FR, Bailey K, Keyte JW, Chan WC, Greenwood D, Mahida YR. Potential role of epithelial cell-derived histone H1 proteins in innate antimicrobial defense in the human gastrointestinal tract. Infect. Immun. 66(7), 3255-3263 (1998).
21. Silphaduang U, Hincke MT, Nys Y, Mine Y. Antimicrobial proteins in chicken reproductive system. Biochem. Biophys. Res. Commun. 340(2), 648-655 (2006).
22. Abrams ST, Zhang N, Manson J et al. Circulating histones are mediators of trauma-associated lung injury. Am. J. Respir. Crit. Care Med. 187(2), 160-169 (2013).
23. Richards RC, O'Neil DB, Thibault P, Ewart KV. Histone H1: an antimicrobial protein of Atlantic salmon (Salmo salar). Biochem. Biophys. Res. Commun. 284(3), 549-555 (2001).
24. Tamura M, Natori K, Kobayashi M, Miyamura T, Takeda N. Inhibition of attachment of virions of Norwalk virus to mammalian cells by soluble histone molecules. Arch. Virol. 148(9), 1659-1670 (2003).
25. Kashima M. H1 histones contribute to candidacidal activities of human epidermal extract. J. Dermatol. 18(12), 695-706 (1991).
26. Fernandes JM, Molle G, Kemp GD, Smith VJ. Isolation and characterisation of oncorhyncin II, a histone H1-derived antimicrobial peptide from skin secretions of rainbow trout, Oncorhynchus mykiss. Dev. Comp. Immunol. 28(2), 127-138 (2004).
27. Luders T, Birkemo GA, Nissen-Meyer J, Andersen O, Nes IF. Proline conformationdependent antimicrobial activity of a proline-rich histone h1 N-terminal Peptide fragment isolated from the skin mucus of Atlantic salmon. Antimicrob. Agents Chemother. 49(6), 2399-2406 (2005).
28. Patrzykat A, Zhang L, Mendoza V, Iwama GK, Hancock RE. Synergy of histone-derived peptides of coho salmon with lysozyme and flounder pleurocidin. Antimicrob. Agents Chemother. 45(5), 1337-1342 (2001).
29. Patat SA, Carnegie RB, Kingsbury C, Gross PS, Chapman R, Schey KL. Antimicrobial activity of histones from hemocytes of the Pacific white shrimp. Eur. J. Biochem. 271(23-24), 4825-4833 (2004).
30. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science 303(5663), 1532-1535 (2004).
31. Hoeksema M, Tripathi S, White M et al. Arginine-rich histones have strong antiviral activity for influenza A viruses. Innate Immun. 21(7), 736-745 (2015).
32. Guimaraes-Costa AB, Nascimento MT, Froment GS et al. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc. Natl Acad. Sci. USA 106(16), 6748-6753 (2009).
33. Wang Y, Chen Y, Xin L et al. Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes. Infect. Immun. 79(3), 1124-1133 (2011).
34. Birkemo GA, Luders T, Andersen O, Nes IF, Nissen-Meyer J. Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.). Biochim. Biophys. Acta 1646(1-2), 207-215 (2003).
35. Park IY, Park CB, Kim MS, Kim SC. Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. FEBS Lett. 437(3), 258-262 (1998).
36. Cho JH, Sung BH, Kim SC. Buforins: histone H2A-derived antimicrobial peptides from toad stomach. Biochim. Biophys. Acta 1788(8), 1564-1569 (2009).
37. Cho JH, Park IY, Kim HS, Lee WT, Kim MS, Kim SC. Cathepsin D produces antimicrobial peptide parasin I from histone H2A in the skin mucosa of fish. FASEB J. 16(3), 429-431 (2002).
38. Park CB, Yi KS, Matsuzaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl Acad. Sci. USA 97(15), 8245-8250 (2000).
39. Tagai C, Morita S, Shiraishi T, Miyaji K, Iwamuro S. Antimicrobial properties of arginine- and lysine-rich histones and involvement of bacterial outer membrane protease T in their differential mode of actions. Peptides 32(10), 2003-2009 (2011).
40. Kobiyama K, Takeshita F, Jounai N et al. Extrachromosomal histone H2B mediates innate antiviral immune responses induced by intracellular double-stranded DNA. J. Virol. 84(2), 822-832 (2010).
41. Morita S, Tagai C, Shiraishi T, Miyaji K, Iwamuro S. Differential mode of antimicrobial actions of arginine-rich and lysine-rich histones against Gram-positive Staphylococcus aureus. Peptides 48, 75-82 (2013).
42. Lemaire S, Rogers C, Dumont M et al. Histogranin, a modified histone H4 fragment endowed with N-methyl-d-aspartate antagonist and immunostimulatory activities. Life Sci. 56(15), 1233-1241 (1995).
43. Lemaire S, Trinh TT, Le HT et al. Antimicrobial effects of H4-(86-100), histogranin and related compounds-possible involvement of DNA gyrase. FEBS J. 275(21), 5286-5297 (2008).
44. Miller BF, Abrams R, Dorfman A, Klein M. Antibacterial properties of protamine and histone. Science 96(2497), 428-430 (1942).
45. Hirsch JG. Bactericidal action of histone. J. Exp. Med. 108(6), 925-944 (1958).
46. Kim HS, Cho JH, Park HW, Yoon H, Kim MS, Kim SC. Endotoxin-neutralizing antimicrobial proteins of the human placenta. J. Immunol. 168(5), 2356-2364 (2002).
47. Fernandes JM, Kemp GD, Molle MG, Smith VJ. Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss. Biochem. J. 368(Pt 2), 611-620 (2002).
48. Kawasaki H, Iwamuro S, Goto Y, Nielsen PF, Conlon JM. Characterization of a hemolytic protein, identified as histone H4, from the skin of the Japanese tree frog Hyla japonica (Hylidae). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 149(1), 120-125 (2008).
49. Raj PA, Antonyraj KJ, Karunakaran T. Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347 Pt 3, 633-641 (2000).
50. Augusto LA, Decottignies P, Synguelakis M, Nicaise M, Le Marechal P, Chaby R. Histones: a novel class of lipopolysaccharidebinding molecules. Biochemistry 42(13), 3929-3938 (2003).
51. Murphy EC, Mohanty T, Frick IM. FAF and SufA: proteins of Finegoldia magna that modulate the antibacterial activity of histones. J. Innate Immun. 6(3), 394-404 (2014).
52. Connolly JH. Effect of histones and protamine on the infectivity of Semliki Forest virus and its ribonucleic acid. Nature 212(5064), 858 (1966).
53. Urban CF, Reichard U, Brinkmann V, Zychlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 8(4), 668-676 (2006).
54. Gadebusch HH, Johnson AG. Natural host resistance to infection with Cryptococcus neoformans. IV. The effect of some cationic proteins on the experimental disease. J. Infect. Dis. 116(5), 551-565 (1966).
55. Kawasaki H, Iwamuro S. Potential roles of histones in host defense as antimicrobial agents. Infect. Disord. Drug Targets 8(3), 195-205 (2008).
56. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244(1), 253-257 (1998).
57. Uyterhoeven ET, Butler CH, Ko D, Elmore DE. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II. FEBS Lett. 582(12), 1715-1718 (2008).
58. Koo YS, Kim JM, Park IY et al. Structure- activity relations of parasin I, a histone H2A-derived antimicrobial peptide. Peptides 29(7), 1102-1108 (2008).
59. Bustillo ME, Fischer AL, Labouyer MA, Klaips JA, Webb AC, Elmore DE. Modular analysis of hipposin, a histone-derived antimicrobial peptide consisting of membrane translocating and membrane permeabilizing fragments. Biochim. Biophys. Acta 1838(9), 2228-2233 (2014).
60. Segal AW. How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197-223 (2005).
61. Cheng OZ, Palaniyar N. NET balancing: a problem in inflammatory lung diseases. Front. Immunol. 4, 1 (2013).
62. Urban CF, Ermert D, Schmid M et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5(10), e1000639 (2009).
63. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell. Biol. 191(3), 677-691 (2010).
64. Dwivedi N, Neeli I, Schall N et al. Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity. FASEB J. 28(7), 2840-2851 (2014).
65. Halverson TW, Wilton M, Poon KK, Petri B, Lewenza S. DNA is an antimicrobial component of neutrophil extracellular traps. PLoS Pathog. 11(1), e1004593 (2015).
66. Lewis HD, Liddle J, Coote JE et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat. Chem. Biol. 11(3), 189-191 (2015).
67. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207(9), 1853-1862 (2010).
68. Martinod K, Fuchs TA, Zitomersky NL et al. PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. Blood 125(12), 1948-1956 (2015).
69. Nauseef WM. Proteases, neutrophils, and periodontitis: the NET effect. J. Clin. Invest. 124(10), 4237-4239 (2014).
70. Sorensen OE, Clemmensen SN, Dahl SL et al. Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses. J. Clin. Invest. 124(10), 4539-4548 (2014).
71. Pilsczek FH, Salina D, Poon KK et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185(12), 7413-7425 (2010).
72. Yipp BG, Kubes P. NETosis: how vital is it? Blood 122(16), 2784-2794 (2013).
73. Yipp BG, Petri B, Salina D et al. Infectioninduced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18(9), 1386-1393 (2012).
74. Douda DN, Khan MA, Grasemann H, Palaniyar N. SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc. Natl Acad. Sci. USA 112(9), 2817-2822 (2015).
75. Keshari RS, Jyoti A, Dubey M et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS ONE 7(10), e48111 (2012).
76. Jenne CN, Kubes P. Virus-induced NETs-critical component of host defense or pathogenic mediator? PLoS Pathog. 11(1), e1004546 (2015).
77. Tripathi S, Verma A, Kim EJ, White MR, Hartshorn KL. LL-37 modulates human neutrophil responses to influenza A virus. J. Leukoc. Biol. 96(5), 931-938 (2014).
78. Narasaraju T, Yang E, Samy RP et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179(1), 199-210 (2011).
79. Hemmers S, Teijaro JR, Arandjelovic S, Mowen KA. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE 6(7), e22043 (2011).
80. Jenne CN, Wong CH, Zemp FJ et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13(2), 169-180 (2013).
81. Kahlenberg JM, Carmona-Rivera C, Smith CK, Kaplan MJ. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J. Immunol. 190(3), 1217-1226 (2013).
82. Lande R, Ganguly D, Facchinetti V et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl Med. 3(73), 73ra19 (2011).
83. Hakkim A, Furnrohr BG, Amann K et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl Acad. Sci. USA 107(21), 9813-9818 (2010).
84. Saffarzadeh M, Preissner KT. Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection. Curr. Opin Hematol. 20(1), 3-9 (2013).
85. Marcos V, Zhou Z, Yildirim AO et al. CXCR2 mediates NADPH oxidaseindependent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat. Med. 16(9), 1018-1023 (2010).
86. Grabcanovic-Musija F, Obermayer A, Stoiber W et al. Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation. Respir. Res. 16, 59 (2015).
87. Saffarzadeh M, Juenemann C, Queisser MA et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 7(2), e32366 (2012).
88. Kutcher ME, Xu J, Vilardi RF, Ho C, Esmon CT, Cohen MJ. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J. Trauma Acute Care Surg. 73(6), 1389-1394 (2012).
89. Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb. Haemost. 9(9), 1795-1803 (2011).
90. Semeraro F, Ammollo CT, Morrissey JH et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118(7), 1952-1961 (2011).
91. Johansson PI, Windelov NA, Rasmussen LS, Sorensen AM, Ostrowski SR. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J. Emerg. Trauma Shock 6(3), 171-175 (2013).
92. Fuchs TA, Bhandari AA, Wagner DD. Histones induce rapid and profound thrombocytopenia in mice. Blood 118(13), 3708-3714 (2011).
93. Huang H, Chen HW, Evankovich J et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J. Immunol. 191(5), 2665-2679 (2013).
94. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J. Immunol. 187(5), 2626-2631 (2011).
95. Abrams ST, Zhang N, Dart C et al. Human CRP defends against the toxicity of circulating histones. J. Immunol. 191(5), 2495-2502 (2013).
96. Bosmann M, Grailer JJ, Ruemmler R et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J. 27(12), 5010-5021 (2013).
97. Caudrillier A, Kessenbrock K, Gilliss BM et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122(7), 2661-2671 (2012).
98. Caudrillier A, Looney MR. Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injury. Curr. Pharm. Des. 18(22), 3260-3266 (2012).
99. Nakahara M, Ito T, Kawahara K et al. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism. PLoS ONE 8(9), e75961 (2013).
100. Martinod K, Demers M, Fuchs TA et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl Acad. Sci. USA 110(21), 8674-8679 (2013).
101. Xu J, Zhang X, Pelayo R et al. Extracellular histones are major mediators of death in sepsis. Nat. Med. 15(11), 1318-1321 (2009).
102. Chaaban H, Keshari RS, Silasi-Mansat R et al. Inter-alpha inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury. Blood 125(14), 2286-2296 (2015).
103. Tripathi S, White MR, Wang G, Hartshorn K. LL-37 modulates human phagocyte responses to influenza A virus. J. Leukoc. Biol. 96(5), 931-938 (2014).
104. Tecle T, Tripathi S, Hartshorn KL. Review: defensins and cathelicidins in lung immunity. Innate Immun. 16(3), 151-159 (2010).
105. Yang D, Liu ZH, Tewary P, Chen Q, De La Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Curr. Pharm. Des. 13(30), 3131-3139 (2007).
106. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin Immunol. 17(4), 359-365 (2005).
107. Tripathi S, White MR, Hartshorn KL. The amazing innate immune response to influenza A virus infection. Innate Immun. 21(1), 73-98 (2015).
108. Otte JM, Zdebik AE, Brand S et al. Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul. Pept. 156(1-3), 104-117 (2009).
109. Carretero M, Escamez MJ, Garcia M et al. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest. Dermatol. 128(1), 223-236 (2008).